Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Schoepp

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Brain Research|January 3, 2001
Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatumJ Cartmell, C R Salhoff, K W Perry, et al.
Journal of Neurochemistry|September 1, 1985
Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolismA J Azzaro, J King, J Kotzuk, et al.
Journal of Neurochemistry|August 1, 1994
3,5-dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampusD D Schoepp, J Goldsworthy, B G Johnson, et al.
Journal of Neurochemistry|August 11, 2000
The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving ratJ Cartmell, K W Perry, C R Salhoff, et al.
Neuropharmacology|May 30, 2009
Use of MGLUR2 and MGLUR3 knockout mice to explore in vivo receptor specificity of the MGLUR2/3 selective antagonist LY341495A-M Linden, B G Johnson, Nina Trokovic, et al.
Psychopharmacology|December 25, 2004
Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out miceA-M Linden, H Shannon, M Baez, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
[3H]LY341495 binding to group II metabotropic glutamate receptors in rat brainR A Wright, M B Arnold, W J Wheeler, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 4, 2001
Binding of [3H](2S,1'S,2'S)-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypesR A Wright, M B Arnold, W J Wheeler, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 28, 1998
Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonistD D Schoepp, B G Johnson, R A Wright, et al.
European Journal of Pharmacology|July 17, 1990
Excitatory amino acid-induced convulsions in neonatal rats mediated by distinct receptor subtypesD D Schoepp, A Y Gamble, C R Salhoff, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Brain Research|January 3, 2001
Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatumJ Cartmell, C R Salhoff, K W Perry, et al.
Journal of Neurochemistry|September 1, 1985
Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolismA J Azzaro, J King, J Kotzuk, et al.
Journal of Neurochemistry|August 1, 1994
3,5-dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampusD D Schoepp, J Goldsworthy, B G Johnson, et al.
Journal of Neurochemistry|August 11, 2000
The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving ratJ Cartmell, K W Perry, C R Salhoff, et al.
Neuropharmacology|May 30, 2009
Use of MGLUR2 and MGLUR3 knockout mice to explore in vivo receptor specificity of the MGLUR2/3 selective antagonist LY341495A-M Linden, B G Johnson, Nina Trokovic, et al.
Psychopharmacology|December 25, 2004
Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out miceA-M Linden, H Shannon, M Baez, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
[3H]LY341495 binding to group II metabotropic glutamate receptors in rat brainR A Wright, M B Arnold, W J Wheeler, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 4, 2001
Binding of [3H](2S,1'S,2'S)-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypesR A Wright, M B Arnold, W J Wheeler, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 28, 1998
Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonistD D Schoepp, B G Johnson, R A Wright, et al.
European Journal of Pharmacology|July 17, 1990
Excitatory amino acid-induced convulsions in neonatal rats mediated by distinct receptor subtypesD D Schoepp, A Y Gamble, C R Salhoff, et al.
Pageof 13